Response to chemotherapeutic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells Cell Line Neoplastic Stem Cells HL-60 Cells K562 Cells HT29 Cells Mitochondria KB Cells MCF-7 Cells HeLa Cells Cells, Cultured Hep G2 Cells

Organisms6

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae Rats, Nude Mice, Inbred C57BL

Diseases32

Neoplasms Breast Neoplasms Lung Neoplasms Colonic Neoplasms Ovarian Neoplasms Neoplasms, Experimental Brain Neoplasms Pancreatic Neoplasms Osteosarcoma Melanoma Adenocarcinoma Liver Neoplasms Glioma Prostatic Neoplasms Leukemia Glioblastoma Colorectal Neoplasms Carcinoma, Hepatocellular Carcinoma, Non-Small-Cell Lung Leukemia L1210 Neuroblastoma Carcinoma Mammary Neoplasms, Experimental Bone Neoplasms Neoplasm Metastasis Peripheral Nervous System Diseases Disease Models, Animal Carcinoma, Squamous Cell Melanoma, Experimental Neovascularization, Pathologic Cholangiocarcinoma Carcinoma, Small Cell

Chemicals and Drugs135

Antineoplastic Agents Doxorubicin Cisplatin Antineoplastic Agents, Phytogenic Paclitaxel Antibiotics, Antineoplastic Etoposide Fluorouracil Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic P-Glycoprotein Vincristine Mitomycin Deoxycytidine Tumor Suppressor Protein p53 Carmustine Dacarbazine Camptothecin Proto-Oncogene Proteins c-bcl-2 Vinblastine Cyclophosphamide Daunorubicin Caspases Methotrexate Taxoids Noscapine Melphalan Bleomycin Hycanthone RNA, Small Interfering Apoptosis Regulatory Proteins bcl-X Protein Thioguanine Cytarabine Neoplasm Proteins Poly(ADP-ribose) Polymerases Caspase 3 Enzyme Inhibitors Mitoxantrone Alkylating Agents Lomustine Tubulin Modulators Multidrug Resistance-Associated Proteins bcl-2-Associated X Protein Organoplatinum Compounds Carboplatin Radiation-Sensitizing Agents Cardiotoxins Prodrugs Mechlorethamine Nitrosourea Compounds Drug Carriers RNA, Messenger Topotecan Isocoumarins Tetrazolium Salts TNF-Related Apoptosis-Inducing Ligand Nitrogen Mustard Compounds Arsenicals Tilorone Proto-Oncogene Proteins c-akt Gossypol NF-kappa B 6-Mercaptopurine Pyrazines Boronic Acids Proto-Oncogene Proteins Floxuridine Topoisomerase II Inhibitors Dimetridazole Protein Kinase Inhibitors ATP-Binding Cassette Transporters Receptors, TNF-Related Apoptosis-Inducing Ligand Nitroimidazoles Mitomycins Thymidylate Synthase Inhibitor of Apoptosis Proteins Antiprotozoal Agents Piperazines DNA Topoisomerases, Type II Topoisomerase I Inhibitors Antibodies, Monoclonal Amsacrine Dactinomycin X-Linked Inhibitor of Apoptosis Protein Xanthones Trypanocidal Agents Anthracyclines DNA, Neoplasm Indoles Oligonucleotides, Antisense O(6)-Methylguanine-DNA Methyltransferase Stilbenes DNA-Binding Proteins Platinum Guanine Glutathione Zinostatin Curcumin Oxides Plant Extracts Protein-Serine-Threonine Kinases Reactive Oxygen Species Naphthoquinones Caspase 7 Myeloid Cell Leukemia Sequence 1 Protein Nuclear Proteins Cyclin-Dependent Kinase Inhibitor p21 Dioxoles Tumor Suppressor Proteins Mebendazole Formazans DNA Angiogenesis Inhibitors Topoisomerase Inhibitors Quinazolines Nanocapsules Thiazoles Uracil Mustard Teniposide Thiotepa Organoselenium Compounds Antimitotic Agents Cytochromes c Benzoquinones Fenretinide Pyrimidines DNA Adducts Caspase 9 Triterpenes Tetrahydroisoquinolines Anticarcinogenic Agents Flavonoids Caspase Inhibitors Nimustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment34

Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Inhibitory Concentration 50 Neoplasm Transplantation Drug Delivery Systems Blotting, Western Combined Modality Therapy Drug Evaluation, Preclinical Neoplasms, Experimental Transplantation, Heterologous Transfection Flow Cytometry Drug Carriers Tumor Stem Cell Assay Reverse Transcriptase Polymerase Chain Reaction Tumor Burden Drug Administration Schedule Treatment Outcome In Situ Nick-End Labeling Clinical Trials as Topic Subrenal Capsule Assay Immunohistochemistry Colony-Forming Units Assay Mammary Neoplasms, Experimental Genetic Therapy Drug Design Models, Biological Molecular Targeted Therapy Gene Knockdown Techniques Nanocapsules Disease Models, Animal Immunoblotting Melanoma, Experimental

Phenomena and Processes36

Drug Resistance, Neoplasm Apoptosis Drug Synergism Cell Survival Drug Resistance, Multiple Dose-Response Relationship, Drug Cell Proliferation Inhibitory Concentration 50 Cell Cycle DNA Damage Gene Expression Regulation, Neoplastic Cell Division Drug Resistance Cell Death Signal Transduction Time Factors Transfection Down-Regulation DNA Repair Cell Growth Processes Enzyme Activation Drug Interactions RNA Interference Genes, p53 Up-Regulation Genes, MDR Phosphorylation DNA Fragmentation Gene Expression Molecular Structure Convection G2 Phase Cell Cycle Checkpoints DNA Adducts Gene Silencing Membrane Potential, Mitochondrial

Disciplines and Occupations3

Nanomedicine Immunohistochemistry Drug Design

Technology, Industry, Agriculture3

Nanomedicine Nanoparticles Nanocapsules

Information Science1

Molecular Sequence Data

Health Care2

Treatment Outcome Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Health Care

Antineoplastic Agents Doxorubicin Drug Resistance, Neoplasm Cell Line, Tumor Apoptosis Cisplatin Drug Synergism Antineoplastic Agents, Phytogenic Paclitaxel Antibiotics, Antineoplastic Tumor Cells, Cultured Cell Survival Etoposide Drug Screening Assays, Antitumor Neoplasms Drug Resistance, Multiple Fluorouracil Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays P-Glycoprotein Dose-Response Relationship, Drug Mice, Nude Cell Proliferation Vincristine Inhibitory Concentration 50 Mitomycin Cell Cycle Deoxycytidine Tumor Suppressor Protein p53 Carmustine Dacarbazine Camptothecin Breast Neoplasms Proto-Oncogene Proteins c-bcl-2 Vinblastine DNA Damage Cyclophosphamide Daunorubicin Lung Neoplasms Gene Expression Regulation, Neoplastic Caspases Methotrexate Neoplasm Transplantation Drug Delivery Systems Taxoids Cell Division Noscapine Melphalan Drug Resistance Blotting, Western Colonic Neoplasms Combined Modality Therapy Bleomycin Hycanthone Drug Evaluation, Preclinical Cell Death RNA, Small Interfering Ovarian Neoplasms Apoptosis Regulatory Proteins Neoplasms, Experimental Transplantation, Heterologous bcl-X Protein Signal Transduction Time Factors Thioguanine Transfection Cytarabine Neoplasm Proteins Poly(ADP-ribose) Polymerases Caspase 3 Enzyme Inhibitors Mitoxantrone Alkylating Agents Flow Cytometry Lomustine Down-Regulation Tubulin Modulators Multidrug Resistance-Associated Proteins bcl-2-Associated X Protein Brain Neoplasms Mice, SCID HCT116 Cells Mice, Inbred BALB C Organoplatinum Compounds Carboplatin Radiation-Sensitizing Agents DNA Repair Cardiotoxins Cell Line Prodrugs Mechlorethamine Pancreatic Neoplasms Nitrosourea Compounds Drug Carriers Osteosarcoma Melanoma RNA, Messenger Tumor Stem Cell Assay

No FAQ available that match "response to chemotherapeutic agents"